SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-19-012205
Filing Date
2019-07-08
Accepted
2019-07-08 16:06:12
Documents
5
Period of Report
2019-08-16
Effectiveness Date
2019-07-08

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT def14a2019_adial.htm DEF 14A 944232
2 GRAPHIC adial_logo1.jpg GRAPHIC 119748
3 GRAPHIC adial_logo11.jpg GRAPHIC 119751
4 GRAPHIC proxycard001.jpg GRAPHIC 1155229
5 GRAPHIC proxycard002.jpg GRAPHIC 534385
  Complete submission text file 0001213900-19-012205.txt   3560288
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38323 | Film No.: 19945402
SIC: 2834 Pharmaceutical Preparations